Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2003
10/14/2003US6632418 Radioligands and their use for identifying potassium channel modulators
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082849A1 Chromene compound
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082830A1 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors
10/09/2003WO2003082593A1 Optical recording media and dipyrromethene-metal chelate compounds
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082298A1 Statin therapy for enhancing cognitive maintenance
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082192A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003US20030191322 Synthetic pathway from reacting chemical intermediates 4-carboxy oxazoline with a formyl amide, decarboxylation, hydroxylation, decyclization, lactamization, saponification; proteasome inhibitors, antiinflammatory, antitumor agents
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191098 Synergistic mixture of thalidomide antiinflammatory agnets
10/09/2003US20030191089 Anticancer agents
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/08/2003EP1349861A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349854A1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1141137B1 Water-soluble rhodamine dyes and conjugates thereof
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP0626967B1 Process for preparing enantiomerically pure fluorinated epoxychromans
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630594 Spiro-pyran compounds; use as pesticides and herbicides
10/07/2003US6630495 Compound containing 2-pyridyl or its N-oxide
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080623A1 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
10/02/2003WO2003080596A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
10/02/2003WO2003080595A1 Blue 3h-naphtho-[2,1-b]-pyran derivatives and use thereof
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003US20030187147 Reacting a iminoester with polymer
10/02/2003US20030187051 Anticholesterol agents, cardiovascular disorders, hypotensive agents, antidiabetic agents, antitumor agents
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187027 Dioxanes and uses thereof
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187012 Reduction physical cigarette smoking
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003CA2479394A1 Process for the production of norgalanthamine, and isomers, salts and hydrates thereof
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1347982A2 Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347957A1 Delta 1-pyrrolines used as pesticides
10/01/2003EP1097154B1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446106A Method of treating estrogen receptor positive carcinoma
10/01/2003CN1445227A Method for extracting total alkaloid of corydalis rhizome and its new usage
10/01/2003CN1122668C Epothilone derivatives and their preparation method and their use as antitumor agents
09/2003
09/30/2003US6627650 An isomer thereof, or an addition salt thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same which are useful as anti- cancer agents.
09/30/2003US6627641 Antimalarial naphthylisoquinoline alkaloid derivatives, methods for obtaining such derivatives, and methods of using such antimalarial compounds for the prevention of malaria infections in mammals and for treating mammals with malarial
09/30/2003US6627639 Useful in the treatment of central nervous system disorders including depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, sexual dysfunction, eating disorders and addictive disorders caused by ethanol or
09/30/2003US6627636 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis
09/30/2003US6627634 Antitumor agents, treatment of the lungs and respiratory tract
09/30/2003US6627604 Memno peptides, process for their preparation and use thereof
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078411A1 C3-cyano epothilone derivatives
09/25/2003WO2003022847A3 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
09/25/2003WO2003013537A3 Irinotecan for treatment of cancer
09/25/2003WO2003013535A3 Use of irinotecan for improved treatment of cancer based on mdr1
09/25/2003WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
09/25/2003WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
09/25/2003US20030181728 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
09/25/2003US20030181587 Thermoplastic resin composition
09/25/2003US20030181502 Methods of treating sepsis
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181477 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/25/2003US20030181476 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/25/2003US20030181467 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
09/25/2003US20030181457 Tertiary amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular and sexual disorders
09/25/2003US20030181422 Cardioprotective phosphonates and malonates
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/24/2003EP1346993A1 Lactam compounds and medicinal use thereof
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345923A1 Azinyl sulfonylimidazoles for use as microbicidal agents
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1268482B1 Pyranoindoles for treating glaucoma
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003CN1444586A Indolinospiropyran compounds and methods for their manufacture
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444481A Protease inhibitors
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 298